This trial is looking at a drug called Spironolactone to see whether it helps reduce heart disease and kidney damage in people with chronic kidney disease.
The trial is currently in the long term follow up stage of recruited participants.
The results of this research trial will be published in a scientific medical journal and on the study website.
Thank you to the 9 patients from BMG who have taken part in Barack-D.
Functional Cookies are enabled by default at all times so that we can save your preferences for cookie settings and ensure site works and delivers best experience.
3rd Party Cookies
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.